Latest market price
3.36
-0.36-9.68%
OverviewShort InterestFilings
NNNNQT30Anbio Biotechnology Class A Ordinary Shares·NASDAQ
3.36-9.68%

Latest SEC Filings

Form category
DescriptionFilingDocument
Jul 09, 2026F-3ASRF-3ASR
Jun 12, 20263Initial statement of beneficial ownership
Jun 12, 20263Initial statement of beneficial ownership
May 19, 20266-KForeign issuer report
Apr 27, 20266-KForeign issuer report
Apr 09, 202620-F/A20-F/A
Apr 08, 20263Initial statement of beneficial ownership
Apr 08, 20263Initial statement of beneficial ownership
Apr 08, 20263Initial statement of beneficial ownership
Apr 08, 20263Initial statement of beneficial ownership
Apr 08, 20263Initial statement of beneficial ownership
Apr 07, 202620-FAnnual report (foreign issuers)
Feb 17, 20266-KForeign issuer report
Jan 26, 20266-KForeign issuer report
Dec 30, 20256-KForeign issuer report
Nov 13, 20256-KForeign issuer report
Apr 28, 202520-FAnnual report (foreign issuers)
Feb 21, 20256-KForeign issuer report
Feb 19, 2025424B4424B4
Feb 18, 2025CERTCERT
Feb 18, 2025EFFECTNotice of effectiveness
Feb 14, 2025CORRESPCORRESP
Feb 14, 20258-A12B8-A12B
Feb 14, 2025CORRESPCORRESP
Feb 10, 2025F-1/AF-1/A
#1 / 25 of 43
Page
▼
/ 2